Should You Buy Valneva SE Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Valneva SE (VALN) carries a solid Quality of Company rating of 6.0/10. Trading at $6.55, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 1 of 2 CirclFi valuation models project upside for Valneva SE (VALN) at $6.55 — the models are evenly split, with a Quality Score of 6.0/10 and Value-Trap risk of 22/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Valneva SE (VALN) in 2026?
What Is the Bull Case vs the Bear Case for Valneva SE (VALN)?
| Bull case — $6.75 target (+3.0%) | Bear case — $4.43 target (-32.4%) |
|---|---|
| Industry tailwind: first-mover advantage in novel targets could provide meaningful support for Valneva SE's revenue and margin trajectory in the Biotechnology space. | According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model sees the stock as overvalued with a fair value of $4.43 (-32.4%), suggesting that the market price embeds overly optimistic growth assumptions. |
| Industry headwind: competitive pipeline overlap represents a meaningful risk for Valneva SE and its Biotechnology peers. |
How Does VALN Compare to Its Biotechnology Peers?
Valuation data pages: LPCN · PRQR · INMB · ALEC · TSHA · CAI · CADL · KPRX · VRAX · EXEL · INCY
Which Other Stocks Score Like VALN on Quality?
Closest companies to VALN’s Quality of Company score of 6.0/10, across all industries.
- OESX — Orion Energy Systems, Inc. (QOC 6.0) · analysis
- VTRS — Viatris Inc. (QOC 6.0) · analysis
- AIDX — 20/20 Biolabs, Inc. (QOC 6.0) · analysis
- IE — Ivanhoe Electric Inc. (QOC 6.0) · analysis
- BWIN — The Baldwin Insurance Group, Inc. (QOC 6.0) · analysis
- UXIN — Uxin Limited (QOC 6.0) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Biotechnology Screens Does VALN Appear In?
So Is Valneva SE (VALN) Worth Buying in 2026?
Our models don't have a clear verdict on Valneva SE. At $6.55 vs. $5.59 median fair value, the median upside of -14.7% masks significant model disagreement (+35.4% spread). With quality at 6.0/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Valneva SE's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About VALN Stock?
Should I buy VALN stock right now?
Based on CirclFi's multi-model analysis, 1 of 2 models see upside for VALN at $6.55. The models are divided, which means the investment case depends heavily on your assumptions about Valneva SE's future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Valneva SE?
Key risks include: limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Biotechnology companies. Always diversify and consult a financial advisor.
How does VALN compare to its competitors?
Among Biotechnology peers, VALN holds a Quality Score of 6.0/10. Comparable companies include LPCN (QOC 6.1), PRQR (QOC 6.0), INMB (QOC 6.1). The relative ranking helps investors identify whether VALN offers better fundamental quality than alternatives in the same sector.
Is VALN a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. VALN's Quality Score of 6.0/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy VALN at?
CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $4.43 to $6.75. At $6.55, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for VALN.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad